======= DAGLB ======= == Gene Information == * **Official Symbol**: DAGLB * **Official Name**: diacylglycerol lipase beta * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=221955|221955]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NCG7|Q8NCG7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DAGLB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DAGLB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614016|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Lipase 3| |endocannabinoid signaling pathway| |retrograde trans-synaptic signaling by lipid| |retrograde trans-synaptic signaling by endocannabinoid| |diacylglycerol catabolic process| |cannabinoid signaling pathway| |trans-synaptic signaling by endocannabinoid| |trans-synaptic signaling by lipid| |retrograde trans-synaptic signaling| |G protein-coupled glutamate receptor signaling pathway| |diacylglycerol metabolic process| |neuroblast proliferation| |acylglycerol catabolic process| |neutral lipid catabolic process| |neurotransmitter biosynthetic process| |glutamate receptor signaling pathway| |glycerolipid catabolic process| |stem cell proliferation| |arachidonic acid metabolic process| |neural precursor cell proliferation| |hydrolase activity| |neurotransmitter metabolic process| |acylglycerol metabolic process| |neutral lipid metabolic process| |unsaturated fatty acid metabolic process| |icosanoid metabolic process| |long-chain fatty acid metabolic process| |fatty acid derivative metabolic process| |cellular lipid catabolic process| |postsynaptic membrane| |lipid catabolic process| |lysosomal membrane| |fatty acid metabolic process| |regulation of neurotransmitter levels| |glycerolipid metabolic process| |trans-synaptic signaling| |synaptic signaling| |monocarboxylic acid metabolic process| |cell population proliferation| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |cell-cell signaling| |lipid metabolic process| |G protein-coupled receptor signaling pathway| |generation of neurons| |neurogenesis| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-3.74| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|-3.63| |[[:results:exp461|BS-181 20μM R08 exp461]]|-2.78| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|-2.65| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.63| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.46| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.4| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|-1.71| |[[:results:exp93|DABN racemic mixture R03 exp93]]|1.8| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|1.88| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|2.05| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.68| |[[:results:exp33|Rotenone 2μM R00 exp33]]|2.89| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|3.02| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|3.19| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12073 * **Expression level (log2 read counts)**: 6.92 {{:chemogenomics:nalm6 dist.png?nolink |}}